| Literature DB >> 25728318 |
Susheel K Singh1, Will Roeffen2, Gorm Andersen3, Teun Bousema4, Michael Christiansen5, Robert Sauerwein2, Michael Theisen6.
Abstract
The sexual stage Pfs48/45 antigen is a well-established lead candidate for a transmission blocking (TB) vaccine because of its critical role in parasite fertilization. We have recently produced the carboxy-terminal 10C-fragment of Pfs48/45 containing three known epitopes for TB antibodies as a chimera with the N-terminal region of GLURP (R0). The resulting fusion protein elicited high titer TB antibodies in rodents. To increase the relatively low yield of correctly folded Pfs48/45 we have generated a series of novel chimera truncating the 10C-fragments to 6 cysteine residues containing sub-units (6C). All constructs harbor the major epitope I for TB antibodies. One of these sub-units (R0.6Cc), produced high yields of correctly folded conformers, which could be purified by a simple 2-step procedure. Purified R0.6Cc was stable and elicits high titer TB antibodies in rats. The yield, purity and stability of R0.6Cc allows for further clinical development.Entities:
Keywords: GLURP; Pfs48/45; Plasmodium falciparum; SMFA; Transmission blocking
Mesh:
Substances:
Year: 2015 PMID: 25728318 DOI: 10.1016/j.vaccine.2015.02.040
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641